Follow the 窪田製薬ホールディングス株式会社 stock price and the full management transaction log of the company, a listed issuer based in Japan. Shares trade on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 窪田製薬ホールディングス株式会社 has logged 63 reports. Market capitalisation: €9.3bn. The latest transaction was disclosed on 14 July 2026 (Holding update). Among the most active insiders: Barclays Bank PLC. The full history is accessible without an account.
63
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
17Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,775 of 28,551 companies
11.6
score / 100
Value
19
Quality
4
FCF yld-6.1%
Earn yld-7.0%
EV/EBITDA·
ROE-51%
Gross mgn-22%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Kubota Pharmaceutical Holdings Co., Ltd. es una empresa japonesa centrada en el sector de la salud y la farmacia. Se especializa en el desarrollo de tratamientos y soluciones terapéuticas innovadoras.
